We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Oxford Genetics Licenses CRISPR Gene Editing Technology from ERS Genomics

News   May 09, 2017 | Original story from Oxford Genetics

 
Oxford Genetics Licenses CRISPR Gene Editing Technology from ERS Genomics
 
 
 

RELATED ARTICLES

Making Resistant Melanomas Susceptible to Immunotherapy

News

A Ludwig Cancer Research study has uncovered a cellular mechanism by which melanomas that fail to respond to checkpoint blockade may be made susceptible to such immunotherapies.

READ MORE

Safeguarding CRISPR Experiments

News

Researchers have demonstrated for the first time how two molecular strategies can safeguard CRISPR gene drive experiments in the lab.

READ MORE

New Genes Associated with the Leading Cause of Blindness

News

Researchers identify genes associated with Age-related Macular Degeneration (AMD) that could represent new targets for future drug development.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE